IRALTONE

Science and innovation for comprehensive Hair Care

Specifically designed formulations for restoring healthy conditions to hair and scalp. Its oral and topical formulas feature a combination of innovative and scientifically-endorsed ingredients for comprehensive and effective treatment of common problems such as hair loss, oily hair, seborrheic dermatitis and dandruff.

Science

Cantabria Labs, as a pharmaceutical company, invests a high percentage (12%) of its turnover in research to ensure maximum scientific efficacy and rigour.

IRALTONE features 5-alpha reductase inhibitors and other ingredients with proven efficacy against hair loss due to hormonal factors. In addition, its innovative Microbioma Balance Tech technology has demonstrated clinical efficacy (2) in contrasting seborrheic dermatitis by rebalancing skin microbiota.

News

IRALTONE

SD Shampoo

Multi-action shampoo to combat all factors responsible for flaking, itching and scalp irritation.

IRALTONE

Fortifying Shampoo

Fortifying shampoo that stimulates hair growth, fights loss, and strengthens hair stand and follicle.

IRALTONE

Sebum-normalizing Shampoo

Shampoo with powerful purifying ingredients to normalise production and secretion of sebum.

Lanzamiento del producto Iraltone Champú Seborregulador

Products

IRALTONE

AGA Capsules

Food supplement formulated for the treatment and prevention of chronic hair loss, ideal as a supplement to other hair-loss treatments.

IRALTONE

FORTE Capsules

Food supplement formulated for acute or seasonal hair loss and fragile hair and nails

IRALTONE

SD Shampoo

Multi-action shampoo to combat all factors responsible for flaking, itching and scalp irritation.

IRALTONE

Fortifying Shampoo

Fortifying shampoo that stimulates hair growth, fights loss, and strengthens hair stand and follicle.

IRALTONE

Sebum-normalizing Shampoo

Shampoo with powerful purifying ingredients to normalise production and secretion of sebum.

IRALTONE

DS Gel

Gel that helps control the signs of seborrheic scaly states that affect the skin of the face

Latest from Communication Area

News 21 Jun 2022